Welcome to Chloe B. Steen’s project group Cancer Biology in Silico

Project group leader
By leveraging different types of gene expression data, we've shown that employing a computational approach can overcome the limitations of experimental methods in the analysis of tissue and cancer heterogeneity. Our research aims to develop and apply computational methods for the identification of rare cell states and their respective microenvironments, with the goal of finding novel therapeutic targets and improving patient outcomes.
The project group is part of the Cancer Genome Variation group, led by Prof. Vessela Kristensen, with vast experience in breast cancer research and genomics.
In addition, Chloe has a 20% position in the Lymphoma Biology Group, led by June H. Myklebust at the Institute for Cancer Research (OUS), and is an associated member of the Newman lab at Stanford University.